Obstetric decision-making and the late and moderately preterm infant

Seminars in Fetal and Neonatal Medicine

Volumn 17, Issue 3, 2012, Pages 132-137

  Gyamfi Bannerman, Cynthia ^a  

^a Department of Medicine   (United States)

Author keywords

Late preterm birth; Prematurity; Respiratory morbidity

Indexed keywords

CESAREAN SECTION; CONNECTIVE TISSUE DISEASE; DELIVERY; FETUS DEATH; FETUS MALFORMATION; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; MEDICAL DECISION MAKING; MULTIPLE PREGNANCY; NEWBORN DEATH; NEWBORN SEPSIS; OBESITY; OLIGOHYDRAMNIOS; PLACENTA ACCRETA; PLACENTA PREVIA; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TOCOLYSIS;

DECISION MAKING; DELIVERY, OBSTETRIC; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREMATURE BIRTH; RISK FACTORS;

EID: 84858750616     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2012.01.014     Document Type: Review

References (52)

1. Altman M., Vanpee M., Cnattingius S., Norman M. Moderately preterm infants and determinants of length of hospital stay. Arch Dis Child Fetal Neonatal Ed 2009, 94:F414-F418.
2. Wooldridge J., Hall W.A. Posthospitalization breastfeeding patterns of moderately preterm infants. J Perinat Neonatal Nurs 2003, 17:50-64.
3. Hibbard J.U., Wilkins I., Sun L., et al. Respiratory morbidity in late preterm births. JAMA 2010, 304:419-425.
4. McIntire D.D., Leveno K.J. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 2008, 111:35-41.
5. Yoder B.A., Gordon M.C., Barth W.H. Late-preterm birth: does the changing obstetric paradigm alter the epidemiology of respiratory complications?. Obstet Gynecol 2008, 111:814-822.
6. Lockwood C.J., Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999, 27:5-20.
7. Anonymous ACOG practice bulletin: management of preterm labor 2003.
8. Holland M.G., Refuerzo J.S., Ramin S.M., Saade G.R., Blackwell S.C. Late preterm birth: how often is it avoidable?. Am J Obstet Gynecol 2009, 201:404.e1-404.e4.
9. Gyamfi-Bannerman C., Fuchs K.M., Young O.M., Hoffman M.K. Nonspontaneous late preterm birth: etiology and outcomes. Am J Obstet Gynecol 2011, 205:456.e1-456.e6.
10. American College of Obstetricians and Gynecologists ACOG practice bulletin: premature rupture of membranes 2007, Number 80.
11. Ramsey P.S., Nuthalapaty F.S., Lu G., Ramin S., Nuthalapaty E.S., Ramin K.D. Contemporary management of preterm premature rupture of membranes (PPROM): a survey of maternal-fetal medicine providers. Am J Obstet Gynecol 2004, 191:1497-1502.
12. Kenyon S., Boulvain M., Neilson J.P. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2010, CD001058.
13. Buchanan S.L., Crowther C.A., Levett K.M., Middleton P., Morris J. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database Syst Rev 2010, CD004735.
14. Morris J.M., Roberts C.L., Crowther C.A., Buchanan S.L., Henderson-Smart D.J., Salkeld G. Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) Trial [ISRCTN44485060]. BMC Pregn Childbirth 2006, 6:9.
15. van der Ham D.P., Nijhuis J.G., Mol B.W., et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial). BMC Pregn Childbirth 2007, 7:11.
16. Koopmans C.M., Bijlenga D., Groen H., et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009, 374:979-988.
17. Habli M., Levine R.J., Qian C., Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007, 197:406.e1-406.e7.
18. Barton J.R., Barton L.A., Istwan N.B., et al. Elective delivery at 34(/) to 36(/) weeks' gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension. Am J Obstet Gynecol 2011, 204:44.e1-44.e5.
19. Melamed N., Pardo J., Milstein R., Chen R., Hod M., Yogev Y. Perinatal outcome in pregnancies complicated by isolated oligohydramnios diagnosed before 37 weeks of gestation. Am J Obstet Gynecol 2011, 205:241.e1-241.e6.
20. Zhang J., Troendle J., Meikle S., Klebanoff M.A., Rayburn W.F. Isolated oligohydramnios is not associated with adverse perinatal outcomes. BJOG 2004, 111:220-225.
21. Sverker E., Andersson A., Johansson A., Kublicas M. Oligohydramnios in uncomplicated pregnancies beyond 40 completed weeks. Fetal Diagn Ther 2005, 20:182-185.
22. Williams' obstetrics 2005, McGraw-Hill, New York. 22nd ed. F.G. Cunningham, J.C. Hauth, K.J. Leveno, L.C. Gilstrap III, S.L. Bloom, K.D. Wenstrom (Eds.).
23. Meehan F.P., Magani I.M. True rupture of the caesarean section scar (a 15 year review, 1972-1987). Eur J Obstet Gynecol Reprod Biol 1989, 30:129-135.
24. Spong C.Y., Mercer B.M., D'Alton M., Kilpatrick S., Blackwell S., Saade G. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011, 118:323-333.
25. Belfort M.A. Placenta accreta. Am J Obstet Gynecol 2010, 203:430-439.
26. Robinson B.K., Grobman W.A. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010, 116:835-842.
27. Oyelese Y., Smulian J.C. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006, 107:927-941.
28. Hull A.D., Resnik R. Placenta previa, placenta accreta, abruptio placentae, and vasa previa. Maternal-fetal medicine: principles and practice 2009, 725-737. Saunders/Elsevier, Philadelphia. 6th ed. R.K. Creasy, R. Resnik, J.D. Iams (Eds.).
29. Williams' obstetrics 2010, McGraw-Hill, New York. 23rd ed. F.G. Cunningham, K.J. Leveno, S.L. Bloom, J.C. Hauth, D.J. Rouse, C.Y. Spong (Eds.).
30. O'Brien T.E., Ray J.G., Chan W.S. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003, 14:368-374.
31. Hajjar I., Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
32. Caritis S., Sibai B., Hauth J., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 338:701-705.
33. Sibai B.M., Lindheimer M., Hauth J., et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998, 339:667-671.
34. Jacobsen S., Petersen J., Ullman S., et al. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 1999, 28:75-80.
35. Williams R.L., Creasy R.K., Cunningham G.C., Hawes W.E., Norris F.D., Tashiro M. Fetal growth and perinatal viability in California. Obstet Gynecol 1982, 59:624-632.
36. Group T.G.S. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. Br J Obstet Gynaecol 2003, 110:27-32.
37. Resnik R., Creasy R.K. Intrauterine growth restriction. Maternal-fetal medicine: principles and practice 2009, 635-650. Saunders/Elsevier, Philadelphia. 6th ed. R.K. Creasy, R. Resnik, J.D. Iams (Eds.).
38. Boers K.E., Vijgen S.M., Bijlenga D., et al. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ 2010, 341:c7087.
39. Thornton J.G., Hornbuckle J., Vail A., Spiegelhalter D.J., Levene M. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004, 364:513-520.
40. Barigye O., Pasquini L., Galea P., Chambers H., Chappell L., Fisk N.M. High risk of unexpected late fetal death in monochorionic twins despite intensive ultrasound surveillance: a cohort study. PLoS Med 2005, 2:e172.
41. Smith N.A., Wilkins-Haug L., Santolaya-Forgas J., et al. Contemporary management of monochorionic diamniotic twins: outcomes and delivery recommendations revisited. Am J Obstet Gynecol 2010, 203:133.e1-133.e6.
42. Lee Y.M., Wylie B.J., Simpson L.L., D'Alton M.E. Twin chorionicity and the risk of stillbirth. Obstet Gynecol 2008, 111:301-308.
43. Craigo S.D. Indicated preterm birth for fetal anomalies. Semin Perinatol 2011, 35:270-276.
44. Tachyarrhythmias. Fetology 2010, 313-319. McGraw-Hill, New York. D.W. Bianchi, T. Crombleholme, M.E. D'Alton, F.D. Malone (Eds.).
45. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG 2003, 110:27-32. GRIT Study Group.
46. Chalubinski K.M., Repa A., Stammler-Safar M., Ott J. The impact of doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth retardation. Ultrasound Obstet Gynecol 2011 May 5, [Epub ahead of print]. 10.1002/uog.9039.
47. Catov J.M., Ness R.B., Kip K.E., Olsen J. Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol 2007, 36:412-419.
48. Sibai B.M. Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol 2011, 205:191-198.
49. Odendaal H.J., Pattinson R.C., Bam R., Grove D., Kotze T.J. Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial. Obstet Gynecol 1990, 76:1070-1075.
50. Sibai B.M., Mercer B.M., Schiff E., Friedman S.A. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994, 171:818-822.
51. Ananth C.V., Vintzileos A.M. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 2006, 19:773-782.
52. Ananth C.V., Gyamfi C., Jain L. Characterizing risk profiles of infants who are delivered at late preterm gestations: does it matter?. Am J Obstet Gynecol 2008, 199:329-331.